Fair enough. As I said before, I personally dont have a depth of knowledge in the space.
The questions in my mind that remain unanswered in this last passage are
1) Are there ANY insights that are gleaned from a double blind. I suspect there may be. Esp if patients are hospitalised and management visually see and engage with nursing (if that indeed occurs) ie they 'dont turn green'
2) Is there any form of written feedback provided post trail AT ALL? Would that be provided to market in all cases?
3) Why would management suggest September given historical timelines? And time taken to date? Usual discussion re timelines I suppose, but still very odd.
4) Did people miss that Footmax was posing a bullish case ?
I think even if Max has a part of this correct eg even just the payment structure its a bullish insight imo
Highlighting not shouting btw
Add to My Watchlist
What is My Watchlist?
